April 25, 2025- Cleveland Clinic has been awarded $7 million from the Patient-Centered Outcomes Research Institute (PCORI) to improve treatment strategies for multiple sclerosis (MS) and hypertension, also known as high blood pressure. The project will extend the multicenter DELIVER-MS study, a three-year randomized clinical trial comparing two treatment approaches in MS head-to-head: starting with an early highly effective treatment approach, using more potent therapies, or an escalation approach beginning with safer but potentially less effective treatments and escalating as needed.
Cleveland Clinic will also introduce a comprehensive hypertension management program across the health system’s internal medicine and family medicine practice sites in Northeast Ohio.